COVID-19 Outcomes Similar in Patients With and Without Immune-Mediated Inflammatory Diseases
Researchers evaluated health records from a large US health system to determine whether common rheumatologic conditions and immunomodulatory drugs were associated with certain COVID-19 outcomes.